Vaxinz Inc.

The startup is developing second-generation vaccines against SARS-CoV-2, utilizing advanced recombinant protein technology to enhance immune response. This approach aims to provide healthcare professionals with effective treatment options to improve patient recovery from COVID-19.

Traction 3/10

Brazil · HQ

Founded 20204200+ followers

Biotechnology

Updated 6 months ago

Funding

Raised to date

$750KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Diego Galeazzi

CEO

Product

Features

The startup is developing second-generation vaccines against SARS-CoV-2, utilizing advanced recombinant protein technology to enhance immune response. This approach aims to provide healthcare professionals with effective treatment options to improve patient recovery from COVID-19.